Acknowledgement
This work was financially supported by the Innovation Cultivation Fund of the Sixth Medical Center of Chinese PLA General Hospital (No. CXPY201827).
References
- Tentolouris A, Vlachakis P, Tzeravini E, Eleftheriadou I, Tentolouris N. SGLT2 inhibitors: a review of their antidiabetic and cardioprotective effects. Int J Environ Res Public Health. 2019;16:2965. https://doi.org/10.3390/ijerph16162965
- Zhang X, Yang L, Xu X, Tang F, Yi P, Qiu B, Hao Y. A review of fibroblast growth factor 21 in diabetic cardiomyopathy. Heart Fail Rev. 2019;24:1005-1017. https://doi.org/10.1007/s10741-019-09809-x
- An H, He L. Current understanding of metformin effect on the control of hyperglycemia in diabetes. J Endocrinol. 2016;228:R97-R106. https://doi.org/10.1530/JOE-15-0447
- Wrobel MP, Marek B, Kajdaniuk D, Rokicka D, SzymborskaKajanek A, Strojek K. Metformin - a new old drug. Endokrynol Pol. 2017;68:482-496. https://doi.org/10.5603/EP.2017.0050
- Natali A, Ferrannini E. Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review. Diabetologia. 2006;49:434-441. https://doi.org/10.1007/s00125-006-0141-7
- Ellul P, Delorme R, Cortese S. Metformin for weight gain associated with second-generation antipsychotics in children and adolescents: a systematic review and meta-analysis. CNS Drugs. 2018;32:1103-1112. https://doi.org/10.1007/s40263-018-0571-z
- Filippatos T, Tzavella E, Rizos C, Elisaf M, Liamis G. Acid-base and electrolyte disorders associated with the use of antidiabetic drugs. Expert Opin Drug Saf. 2017;16:1121-1132. https://doi.org/10.1080/14740338.2017.1361400
- DeFronzo R, Fleming GA, Chen K, Bicsak TA. Metformin-associated lactic acidosis: current perspectives on causes and risk. Metabolism. 2016;65:20-29. https://doi.org/10.1016/j.metabol.2015.10.014
- Lalau JD. Lactic acidosis induced by metformin: incidence, management and prevention. Drug Saf. 2010;33:727-740. https://doi.org/10.2165/11536790-000000000-00000
- Takaki A, Kawai D, Yamamoto K. Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH). Int J Mol Sci. 2013;14:20704-20728. https://doi.org/10.3390/ijms141020704
- Ohta S. Recent progress toward hydrogen medicine: potential of molecular hydrogen for preventive and therapeutic applications. Curr Pharm Des. 2011;17:2241-2252. https://doi.org/10.2174/138161211797052664
- Li S, Liao R, Sheng X, Luo X, Zhang X, Wen X, Zhou J, Peng K. Hydrogen gas in cancer treatment. Front Oncol. 2019;9:696. https://doi.org/10.3389/fonc.2019.00696
- Kamimura N, Nishimaki K, Ohsawa I, Ohta S. Molecular hydrogen improves obesity and diabetes by inducing hepatic FGF21 and stimulating energy metabolism in db/db mice. Obesity (Silver Spring). 2011;19:1396-1403. https://doi.org/10.1038/oby.2011.6
- Aoki K, Nakao A, Adachi T, Matsui Y, Miyakawa S. Pilot study: effects of drinking hydrogen-rich water on muscle fatigue caused by acute exercise in elite athletes. Med Gas Res. 2012;2:12. https://doi.org/10.1186/2045-9912-2-12
- Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. 2008;51:216-226. https://doi.org/10.1007/s00125-007-0886-7
- Scale T, Harvey JN. Diabetes, metformin and lactic acidosis. Clin Endocrinol (Oxf). 2011;74:191-196. https://doi.org/10.1111/j.1365-2265.2010.03891.x
- Bell DSH, Goncalves E. Heart failure in the patient with diabetes: epidemiology, aetiology, prognosis, therapy and the effect of glucose-lowering medications. Diabetes Obes Metab. 2019;21:1277-1290. https://doi.org/10.1111/dom.13652
- Fryer LG, Parbu-Patel A, Carling D. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem. 2002;277:25226-25232. https://doi.org/10.1074/jbc.M202489200
- Hardie DG, Carling D. The AMP-activated protein kinase--fuel gauge of the mammalian cell? Eur J Biochem. 1997;246:259-273. https://doi.org/10.1111/j.1432-1033.1997.00259.x
- Han X, Yang J, Yang K, Zhao Z, Abendschein DR, Gross RW. Alterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes: a shotgun lipidomics study. Biochemistry. 2007;46:6417-6428. https://doi.org/10.1021/bi7004015
- Brucculeri S, Urso C, Caimi G. [The role of lactate besides the lactic acidosis]. Clin Ter. 2013;164:e223-e238. Italian.